A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) | BMC Medicine | Full Text https://t.co/4c7HVpQaNQ
10,455 followers
9,409 followers
RT @BioMedCentral: Camostat mesilate is not an effective treatment for mild to moderate SARS-CoV-2 infection, reports a study published in…
77,115 followers
Camostat mesilate is not an effective treatment for mild to moderate SARS-CoV-2 infection, reports a study published in @BMCMedicine. https://t.co/HPSpcZxEuX
152 followers
RT @EARL_COVID19_tw: 発症から5日以内の新型コロナウイルス感染症患者に対するカモスタットメシル酸はプラセボと有意差なし.本邦155例RCT(BMC Med 2022 Sep27) https://t.co/SYm2sjSt99 だいぶ前にプレスリリースは出…